Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2238256
                    [Title] => What is heart disease? Lisa Marie Presley, her family's history of heart conditions
                    [Summary] => Heart disease, according to the Centers for Disease Control and Prevention, refers to any condition that affects the heart and arteries and is often regarded as a "silent killer" as it is never noticed until an individual experiences a heart attack, heart failure, or an arrhythmia.
                    [DatePublished] => 2023-01-18 10:37:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806731
                    [AuthorName] => Kristofer Purnell
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2023/01/13/lisa-marie-presley-afp-chris-delmas_2023-01-13_12-23-0752_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2079592
                    [Title] => How we can succeed in war vs heart failure
                    [Summary] => Fortunately, there is hope for the heart, with experts saying that heart failure is treatable if caught early.
                    [DatePublished] => 2021-02-22 12:58:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806532
                    [AuthorName] => Ratziel San Juan
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/02/22/heart-failure_2021-02-22_11-21-11631_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1955784
                    [Title] => Failure to prevent most heart failure could be avoided
                    [Summary] => Until the randomized EMPA-REG-OUTCOME trial of the sodium-glucose transporter 2 (SGLT-2) inhibitors empagliflozin (Jardiance), no glucose-lowering drug available for treatment of type 2 diabetes had shown any benefit in terms of reducing diabetic patients’ elevated risk of heart failure.
                    [DatePublished] => 2019-09-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 1953793
                    [Title] => Failure to prevent most heart failure could be avoided
                    [Summary] => More than 960,000 new cases of heart failure will occur in the United States this year – and most of them could have been prevented, asserted at Annual Cardiovascular Conference.
                    [DatePublished] => 2019-09-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1880857
                    [Title] => Intensified approach  cut long-term  heart failure risk  in type 2 diabetes
                    [Summary] => A 70 percent reduction in the risk of hospitalization for heart failure was achieved in people with type 2 diabetes mellitus given an intensified treatment in a long-term follow up of the STENO-2 study.
                    [DatePublished] => 2018-12-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 710240
                    [Title] => Solusyon sa mahina  ang puso (heart failure)
                    [Summary] => MAY sakit na kung tawagin ay Heart Failure, kung saan ay humihina ang masel ng puso.
                    [DatePublished] => 2011-07-28 00:00:00
                    [ColumnID] => 134020
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 176597
                    [Title] => Clinical trial on ‘HF-PSF’ underway
                    [Summary] => BERLIN, Germany – The launch of a new landmark clinical study, I-PRESERVE (Irbesartan in Heart Failure with Preserved Systolic Function), was recently announced at the European Society of Cardiology meeting by its principal investigators, Drs. Peter Carson and Barry Massie, on behalf of the I-PRESERVE study steering committee.


The I-PRESERVE study is supported by a grant from Bristol-Myers Squibb Co. and Sanofi-Synthelabo Inc.


                    [DatePublished] => 2002-09-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

heart failure

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2238256
                    [Title] => What is heart disease? Lisa Marie Presley, her family's history of heart conditions
                    [Summary] => Heart disease, according to the Centers for Disease Control and Prevention, refers to any condition that affects the heart and arteries and is often regarded as a "silent killer" as it is never noticed until an individual experiences a heart attack, heart failure, or an arrhythmia.
                    [DatePublished] => 2023-01-18 10:37:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806731
                    [AuthorName] => Kristofer Purnell
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2023/01/13/lisa-marie-presley-afp-chris-delmas_2023-01-13_12-23-0752_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2079592
                    [Title] => How we can succeed in war vs heart failure
                    [Summary] => Fortunately, there is hope for the heart, with experts saying that heart failure is treatable if caught early.
                    [DatePublished] => 2021-02-22 12:58:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806532
                    [AuthorName] => Ratziel San Juan
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/02/22/heart-failure_2021-02-22_11-21-11631_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1955784
                    [Title] => Failure to prevent most heart failure could be avoided
                    [Summary] => Until the randomized EMPA-REG-OUTCOME trial of the sodium-glucose transporter 2 (SGLT-2) inhibitors empagliflozin (Jardiance), no glucose-lowering drug available for treatment of type 2 diabetes had shown any benefit in terms of reducing diabetic patients’ elevated risk of heart failure.
                    [DatePublished] => 2019-09-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 1953793
                    [Title] => Failure to prevent most heart failure could be avoided
                    [Summary] => More than 960,000 new cases of heart failure will occur in the United States this year – and most of them could have been prevented, asserted at Annual Cardiovascular Conference.
                    [DatePublished] => 2019-09-22 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1880857
                    [Title] => Intensified approach  cut long-term  heart failure risk  in type 2 diabetes
                    [Summary] => A 70 percent reduction in the risk of hospitalization for heart failure was achieved in people with type 2 diabetes mellitus given an intensified treatment in a long-term follow up of the STENO-2 study.
                    [DatePublished] => 2018-12-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 710240
                    [Title] => Solusyon sa mahina  ang puso (heart failure)
                    [Summary] => MAY sakit na kung tawagin ay Heart Failure, kung saan ay humihina ang masel ng puso.
                    [DatePublished] => 2011-07-28 00:00:00
                    [ColumnID] => 134020
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => PSN Opinyon
                    [SectionUrl] => opinyon
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 176597
                    [Title] => Clinical trial on ‘HF-PSF’ underway
                    [Summary] => BERLIN, Germany – The launch of a new landmark clinical study, I-PRESERVE (Irbesartan in Heart Failure with Preserved Systolic Function), was recently announced at the European Society of Cardiology meeting by its principal investigators, Drs. Peter Carson and Barry Massie, on behalf of the I-PRESERVE study steering committee.


The I-PRESERVE study is supported by a grant from Bristol-Myers Squibb Co. and Sanofi-Synthelabo Inc.


                    [DatePublished] => 2002-09-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

What is heart disease? Lisa Marie Presley, her family's history of heart conditions

By Kristofer Purnell | January 18, 2023 - 10:37am

Heart disease, according to the Centers for Disease Control and Prevention, refers to any condition that affects the...

Health And Family

How we can succeed in war vs heart failure

By Ratziel San Juan | February 22, 2021 - 12:58pm

Fortunately, there is hope for the heart, with experts saying that heart failure is treatable if caught early.

Health And Family

Failure to prevent most heart failure could be avoided

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 29, 2019 - 12:00am

Until the randomized EMPA-REG-OUTCOME trial of the sodium-glucose transporter 2 (SGLT-2) inhibitors empagliflozin (Jardiance), no glucose-lowering drug available for treatment of type 2 diabetes had shown any benefit...

Opinion

Failure to prevent most heart failure could be avoided

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 22, 2019 - 12:00am

More than 960,000 new cases of heart failure will occur in the United States this year – and most of them could have been prevented, asserted at Annual Cardiovascular Conference.

Opinion

Intensified approach cut long-term heart failure risk in type 2 diabetes

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 30, 2018 - 12:00am

A 70 percent reduction in the risk of hospitalization for heart failure was achieved in people with type 2 diabetes mellitus given an intensified treatment in a long-term follow up of the STENO-2 study.

Opinion

Solusyon sa mahina ang puso (heart failure)

By Dr. Willie T. Ong | July 28, 2011 - 12:00am

MAY sakit na kung tawagin ay Heart Failure, kung saan ay humihina ang masel ng puso.

PSN Opinyon

Clinical trial on ‘HF-PSF’ underway

September 19, 2002 - 12:00am

BERLIN, Germany – The launch of a new landmark clinical study, I-PRESERVE (Irbesartan in Heart Failure with Preserved Systolic Function), was recently announced at the European Society of Cardiology meeting...

Science and Environment